Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Aims To Reach Positive EBIT, Cash Flow During 2026

Sept 12 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * UPDATES STRATEGIC PLAN
    * AIMS TO REACH POSITIVE EBIT AND CASH FLOW DURING 2026
    * IN NEXT 18 MONTHS CO TO FOCUS ON DELIVERY OF CHS TO
MEDICAL
DEVICE CUSTOMERS

Source text for Eikon:  ID:nGNE1KrNzY 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Corline Biomedical AB

See all news